Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 7/2009

01-07-2009 | Research Article

Serum Phenylalanine Concentration as a Marker of Liver Function in Obese Patients Before and After Bariatric Surgery

Authors: Julian Swierczynski, Tomasz Sledzinski, Ewa Slominska, Ryszard Smolenski, Zbigniew Sledzinski

Published in: Obesity Surgery | Issue 7/2009

Login to get access

Abstract

Background

Human obesity is associated with increased serum phenylalanine concentration, which is probably caused by liver dysfunction related to liver steatosis. This study examines whether improvements of liver function after bariatric surgery is associated with a decrease of serum phenylalanine concentration caused by an increase of phenylalanine metabolism.

Method

Serum phenylalanine and alanine aminotransferase (an independent predictor of liver steatosis) concentrations as well as several parameters related to obesity were measured in 16 obese patients (seven men and nine women) before and 6 months after vertical banded gastroplasty. Ten (six men and four women) lean, healthy subjects served as controls.

Results

Obese patients before surgery had approximately twofold higher serum phenylalanine concentration than control subjects. The serum phenylalanine concentration decreased 6 months after bariatric surgery. Serum alanine aminotransferase (ALT) concentration was higher in obese patients before surgery, and decreased 6 months after bariatric surgery. Changes in serum phenylalanine concentration correlated positively with changes of ALT concentration (r = 0.75; p < 0.001). The body weight, BMI, HOMA-IR, serum triacylglycerol, LDL-cholesterol/HLD-cholesterol ratio, leptin, insulin, and glucose concentrations were higher in obese patients, and decreased 6 months after bariatric surgery. Serum HDL-cholesterol concentration was lower in obese patients before surgery than in control subjects and increased 6 months after surgery.

Conclusion

Results obtained indicate that bariatric surgery-induced weight loss had beneficial effects on several laboratory parameters including serum phenylalanine, ALT, lipid concentrations and insulin resistance. A strong positive correlation between serum phenylalanine and serum ALT concentrations suggests that deterioration of liver function in obese patients is contributing to a decrease in phenylalanine metabolism and consequently to the increase of serum phenylalanine concentration. One can suppose that serum phenylalanine concentration could be noninvasive marker of liver dysfunction associated with liver steatosis in obese patients.
Literature
1.
Pearl RH, Clowes GH, Bosari S, et al. Amino acid clearance in cirrhosis. A predictor of postoperative morbidity and mortality. Arch Surg. 1987;122:468–73.CrossRefPubMed
2.
Zello GA, Pencharz PB, Ball RO. Phenylalanine flux, oxidation, and conversion to tyrosine in humans studied with L [1-13C]phenylalanine. Am J Physiol. 1990;259:E835–43.PubMed
3.
Heberer M, Talke H, Maier KP, et al. Metabolism of phenylalanine in liver diseases. Klin Wochenschr. 1980;58:1189–96.CrossRefPubMed
4.
Holm E, Sedlaczek O, Grips E. Amino acid metabolism in liver disease. Curr Opin Clin Nutr Metab Care. 1999;2:47–53.CrossRefPubMed
5.
Burke PA, Stack JA, Wagner D, et al. L (1-13C]-phenylalaniane oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg. 1997;173:270–3.CrossRefPubMed
6.
Ishii Y, Suzuki S, Kohno T, et al. Patients with severe liver cirrhosis followed up by L- [1-13C]phenylalanine breast test. J Gastroenterol. 2003;38:1086–90.CrossRefPubMed
7.
Ishii Y, Suzuki S, Kohno T, et al. L- [1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res. 2003;114:120–5.CrossRefPubMed
8.
Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepathology. 2003;37:1202–19.CrossRef
9.
Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol. 2004;2:1048–58.CrossRefPubMed
10.
Poynard T, Ratziu V, Charlotte F, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:34.CrossRefPubMedPubMedCentral
11.
12.
Papadia FS, Marinari GM, Camerini G, et al. Liver damage in severely obese patients: a clinical–biochemical–morphologic study on 1,000 liver biopsies. Obes Surg. 2004;14:952–8.CrossRefPubMed
13.
Shalhub S, Parsee A, Gallagher SF, et al. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg. 2004;14:54–9.CrossRefPubMed
14.
Moretto M, Kupski C, Mottin CC, et al. Hepatic steatosis in patients undergoing bariatric surgery and its relationship to body mass index and co-morbidities. Obes Surg. 2003;13:622–4.CrossRefPubMed
15.
Liew PL, Lee WJ, Lee YCh, et al. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg. 2006;16:1584–93.CrossRefPubMed
16.
Dixon JB, Bhathal PS, O’Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentration are associated with histologic improvement. Obes Surg. 2006;16:1278–86.CrossRefPubMed
17.
Talwalkar JA. Motion—all patients with NASH need to have a liver biopsy: arguments for the motion. Can J Gastroenterol. 2002;16:718–21.CrossRefPubMed
18.
Laurin J. Motion—all patients with NASH need to have a liver biopsy: arguments against the motion. Can J Gastroenterol. 2002;16:722–6.CrossRefPubMed
19.
Chang Y, Ryu S, Sung E, et al. Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 2007;53:686–92.CrossRefPubMed
20.
Felig P, Marliss E, Cahill GF. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med. 1969;281:811–6.CrossRefPubMed
21.
Caballero B, Finer N, Wurtman RJ. Plasma amino acids and insulin levels in obesity: response to carbohydrate intake and tryptophan supplements. Metabolism. 1988;37:672–6.CrossRefPubMed
22.
Clark JM, Alkhuraishi AR, Solga SF, et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res. 2005;13:1180–6.CrossRef
23.
Swierczynski J, Korczynska J, Goyke E, et al. Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg. 2005;15:803–8.CrossRefPubMed
24.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.PubMed
25.
Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
26.
Palova S, Charvat J, Masopust J, et al. Changes in the plasma amino acid profile in anorexia nervosa. J Int Med Res. 2007;35:389–94.CrossRefPubMed
27.
Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450–5.CrossRefPubMed
28.
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7.CrossRefPubMed
29.
Myers MG, Cowley MA, Munzberg H. Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 2008;70:537–56.CrossRefPubMed
30.
Nobili V, Manco M, Ciampalini P, et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol. 2006;155:735–43.CrossRefPubMed
31.
Chitturi S, Farrell G, Frost L, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotixicity? Hepatology. 2002;36:403–9.CrossRefPubMed
32.
33.
Zabrocka L, Raczynska S, Goyke E, et al. BMI is the main determinant of the circulating leptin in women after vertical banded gastroplasty. Obes Res. 2004;12:505–12.CrossRefPubMed
34.
Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–59.CrossRefPubMed
Metadata
Title
Serum Phenylalanine Concentration as a Marker of Liver Function in Obese Patients Before and After Bariatric Surgery
Authors
Julian Swierczynski
Tomasz Sledzinski
Ewa Slominska
Ryszard Smolenski
Zbigniew Sledzinski
Publication date
01-07-2009
Publisher
Springer New York
Published in
Obesity Surgery / Issue 7/2009
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-008-9521-z

Other articles of this Issue 7/2009

Obesity Surgery 7/2009 Go to the issue

Research Article

Sleeve Gastrectomy Relieves Steatohepatitis in High-Fat-Diet-Induced Obese Rats

Clinical Research

Evaluation of Bone Disease in Morbidly Obese Women After Gastric Bypass and Risk Factors Implicated in Bone Loss

Research Article

Revisional Bariatric Surgery

Research Article

Inflammatory Response Measured By Body Temperature, C-Reactive Protein and White Blood Cell Count 1, 3, and 5 Days After Laparotomic or Laparoscopic Gastric Bypass Surgery

Modern Surgery: Technical Innovation

The “Tip-Stitch”: A Time-Saving Technique for Specimen Extraction in Sleeve Gastrectomy

Case Report

Small Bowel Obstruction and Internal Hernias during Pregnancy after Gastric Bypass Surgery